Press Releases from Circa Life Sciences (1 total)
Circa Life Sciences Tackles the Rapid Growth of the Medical Cannabis Industry in …
The approval of GW Pharmaceutical’s Epidiolex, an oral solution derived from cannabidiol (CBD), brought about a positive impact in the Colombia market and became a key indicator that cannabis can be used medically.
It has been recommended to treat two difficult types of epilepsy which are Lennox-Gastaut and Dravet syndrome even though there are other medications available. In a clinical trial, 32% of the patients who received 10-milligram…
